Apogee CEO Sells Shares Amid Significant Stock Price Surge

Michael Thomas Henderson, CEO of Apogee Therapeutics (NASDAQ:APGE), sold 20,000 shares under a Rule 10b5-1 trading plan and gifted another 75,046 to charity. The stock has surged by 247% over the past year despite the company reporting a $274.6 million net loss in its trailing twelve months.

By Jonathan Ponciano, The Motley Fool Sun, July 12, 2026 at 8:53 PM GMT+3 4 min read · Yahoo Finance · July 12, 2026, 17:53 UTC

Apogee CEO Sells Shares Amid Significant Stock Price Surge

Tickers: $APGE

Topics: biotech SEC filings stock transactions

Read the full article at Yahoo Finance

More World news

California Supreme Court to Rule on Insurance Overcharge Liability Under Proposition 103 PR Newswire · November 12, 2026, 18:44 UTC
Federal Court Orders Veterans Guardian to Pay Treble Damages to Disabled Veteran Class PR Newswire · November 12, 2026, 18:41 UTC
AIRO Group Holdings Reaffirms 2026 Revenue Growth Guidance Amid $200 Million Drone Backlog Seeking Alpha · November 12, 2026, 18:40 UTC
Nvidia CEO Jensen Huang Resigns Amid Personal Scandal, Raising Uncertainty for Open Source AI Strategy TechCrunch · November 12, 2026, 18:39 UTC
Vor Bio and RemeGen Expand Collaboration for Autoimmune Disease Therapy Seeking Alpha · November 12, 2026, 18:35 UTC
EnterpriseDB Hires CMRD Engineering Team to Strengthen Sovereign AI Governance PR Newswire · November 12, 2026, 18:36 UTC
Alliant Credit Union Executive Meredith Ritchie Named 2027 Chicago Titan 100 Honoree PR Newswire · November 12, 2026, 18:36 UTC
Fed's Schmid Argues Construction Productivity is Key to Housing Affordability Over Interest Rate Cuts Seeking Alpha · November 12, 2026, 18:33 UTC
PROG Holdings Reports 59% GMV Growth and Announces $100 Million Share Repurchase Program Motley Fool · November 12, 2026, 18:30 UTC
Corteva Shares Plunge Over Q3 Earnings Miss and Pricing Pressures Motley Fool · November 12, 2026, 18:31 UTC